You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 7,893,097


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,893,097 protect, and when does it expire?

Patent 7,893,097 protects NUVESSA and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 7,893,097
Title:Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
Abstract: The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid.
Inventor(s): Yang; Meidong (Richmond, CA), Chen; Haigang (Petaluma, CA)
Assignee: Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:12/012,413
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,893,097

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 7,893,097, exploring its claims, scope, and the broader patent landscape it inhabits.

Overview of the Patent

United States Patent 7,893,097, titled "Methods and compositions for increasing the solubility of poorly soluble drugs," addresses a significant challenge in pharmaceuticals: the solubility of certain drugs, particularly those like azole drugs, which are poorly soluble in water[5].

Patent Claims

Independent Claims

The patent includes several independent claims that define the core inventions. These claims are critical as they outline the novel and non-obvious aspects of the invention.

  • Claim 1: This claim typically sets the broadest scope of the invention, describing the method or composition in general terms. For example, it might claim a method for increasing the solubility of a poorly soluble drug using a specific formulation.
  • Claim 2-5: These claims usually narrow down the scope by adding specific limitations or details to the method or composition. For instance, they might specify particular solvents, concentrations, or application methods.

Dependent Claims

Dependent claims build upon the independent claims by adding additional features or limitations. These claims help to further define the invention and can provide additional protection.

  • Dependent Claim Examples: These might include claims that specify the type of drug, the formulation process, or the conditions under which the method is applied.

Scope of the Patent

The scope of a patent is determined by its claims and is a critical factor in assessing its validity and enforceability.

Claim Language and Scope

The language used in the claims is pivotal. Broader claims can provide wider protection but may be more susceptible to challenges based on prior art or obviousness. Narrower claims, while more specific, may offer stronger validity but reduced scope of protection[3].

Patent Scope Metrics

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Patent Examination Process

The examination process plays a significant role in shaping the final scope of the patent.

Enablement Requirement

The patent must meet the enablement requirement, which means that the specification must provide sufficient information for a person of ordinary skill in the art to make and use the invention without undue experimentation[4].

Office Actions and Revisions

During the examination process, the patent office may issue office actions that require the applicant to revise or narrow the claims. This process can significantly impact the final scope of the patent, often resulting in narrower claims than initially filed[3].

Prior Art and Citation Analysis

Understanding the prior art and citation landscape is essential for assessing the novelty and non-obviousness of the patent.

Common Citation Document (CCD)

Tools like the Common Citation Document (CCD) consolidate prior art citations from multiple patent offices, providing a comprehensive view of the prior art landscape for a given invention[1].

Forward and Backward Citations

Analyzing forward and backward citations can provide insights into the patent's impact and its position within the broader technological field. Forward citations indicate how often the patent is cited by later patents, while backward citations show the prior art that the patent builds upon.

International Patent Landscape

Given the global nature of intellectual property, it is important to consider the international patent landscape.

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP offices. This helps in understanding the global reach and protection of the invention[1].

International Patent Databases

Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) offer access to international patent collections, enabling a comprehensive search for prior art and related patents[1].

Practical Implications

Understanding the scope and claims of a patent like US 7,893,097 has practical implications for various stakeholders.

Licensing and Litigation

The clarity and breadth of the claims can affect licensing and litigation costs. Broader claims may lead to more licensing opportunities but also increase the risk of litigation challenges[3].

Innovation Incentives

The scope of the patent can influence innovation incentives. Patents with clear and reasonable scope can encourage further innovation by providing a clear boundary of what is protected and what is not[3].

Key Takeaways

  • Patent Claims: The claims define the scope of the patent and are crucial for understanding what is protected.
  • Scope Metrics: Independent claim length and count can be used to measure patent scope.
  • Examination Process: The patent examination process can significantly narrow the scope of the patent.
  • Prior Art: Understanding prior art through tools like CCD is essential for assessing novelty and non-obviousness.
  • International Landscape: Considering the global patent landscape through services like Global Dossier is vital.

FAQs

  1. What is the main purpose of the claims in a patent?

    • The claims in a patent define the scope of the invention and outline what is protected by the patent.
  2. How does the patent examination process affect the scope of a patent?

    • The examination process can result in narrower claims as applicants may need to revise or limit their claims to overcome office actions.
  3. What is the Common Citation Document (CCD), and how is it useful?

    • The CCD consolidates prior art citations from multiple patent offices, providing a single point of access to up-to-date citation data for a patent application.
  4. Why is it important to consider the international patent landscape?

    • Considering the international patent landscape helps in understanding the global reach and protection of the invention, as well as identifying related patents and prior art.
  5. How do broader claims impact licensing and litigation?

    • Broader claims may lead to more licensing opportunities but also increase the risk of litigation challenges due to potential disputes over the scope of protection.

Sources

  1. USPTO - Search for patents
  2. US Courts - Report on Filing Patent/Trademark
  3. SSRN - Patent Claims and Patent Scope
  4. Federal Register - Guidelines for Assessing Enablement in Utility Applications
  5. Google Patents - US7893097B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,893,097

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chemo Research Sl NUVESSA metronidazole GEL;VAGINAL 205223-001 Mar 24, 2014 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,893,097

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 070406 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2009097143 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.